Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 824-831

  Rossier, Michel F ^a   Ertel, Eric A ^a   Vallotton, Michel B ^a   Capponi, Alessandro M ^a  

^a Faculty of Medicine   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BENZIMIDAZOLE DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; MIBEFRADIL; NICARDIPINE; PIMOZIDE; POTASSIUM CHLORIDE; TETRALIN DERIVATIVE; ANGIOTENSIN; CALCIUM CHANNEL; CALCIUM ION; CORTICOTROPIN; CYCLIC AMP; FORSKOLIN; POTASSIUM; PREGNENOLONE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CATTLE; CELL CULTURE; CYTOSOL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATCH CLAMP; SIGNAL TRANSDUCTION; ZONA GLOMERULOSA; ALDOSTERONE RELEASE; ANIMAL CELL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; HORMONE SYNTHESIS; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; STEADY STATE; STEROIDOGENESIS;

ALDOSTERONE; ANIMALS; BENZIMIDAZOLES; CALCIUM; CALCIUM CHANNEL BLOCKERS; CATTLE; CELLS, CULTURED; CYTOSOL; MIBEFRADIL; NICARDIPINE; PATCH-CLAMP TECHNIQUES; PIMOZIDE; POTASSIUM CHLORIDE; SIGNAL TRANSDUCTION; TETRAHYDRONAPHTHALENES; ZONA GLOMERULOSA;

EID: 0032253670     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Barrett PQ, Isales CM, Bollag WB and McCarthy RT (1991) Calcium channels anc aldosterone secretion: modulation by potassium and atrial natriuretic peptide AmJPhysiol 261:F706-F719.
2. Barrett PQ, Ertel EA, Smith MM, Nee JJ and Cohen CJ (1995) Voltage-gated calcium currents have two opposing effects on the secretion of aldosterone. Am J Physiol 268:C985-C992.
3. Bernink PJ, Prager G, Schelling A and Kobrin I (1996) Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967): A new generation of calcium antagonists? Mibefradil International Study Group. Hypertension 27: 426-432.
4. Bezprozvanny I and Tsien RW (1995) Voltage-dependent blockade of diverse types of voltage-gated calcium channels expressed in Xenopus oocytes by the calcium channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 48:540-549.
5. Bian K and Hermsmeyer K (1993) Calcium channel actions of the nondihydropyridine calcium channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries. Naunyn-Schmiedeberg Arch Pharmacol 348:191-196.
6. Boulanger CM, Desta B, Clozel J-P and Vanhoutte PM (1994a) Chronic treatment with the calcium channel inhibitor Ro 40-5967 potentiates endothelium-dependent relaxations in the aorta of the hypertensive salt sensitive Dahl rat. Blood Press 3:193-196.
7. Boulanger CM, Nakashirna M, Olmos L, Joly G and Vanhoutte PM (1994b) Effects of the calcium antagonist Ro 40-5967 on endothelium-dependent responses of isolated arteries. J Cardiovasc Pharmacol 23:869-876.
8. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72:248-254.
9. Burnay MM, Python CP, Vallotton MB, Capponi AM and Rossier MF (1994) Role of the capacitative calcium influx in the activation of steroidogenesis by angiotensin II in adrenal glomerulosa cells. Endocrinology 135:751-758.
10. Capponi AM and Rossier MF (1996) Regulation of aldosterone secretion. Curr Opinion Endocrinol Diabetes 3:248-257.
11. Cheglakov IB, Bochkov VN and Tkachuk VA (1997) Influence of mibefradil on calcium influx induced by vasoactive hormones or depletion of intracellular calcium stores. Arzneim Forsch Drug Res 47:244-247.
12. Clozel J-P, Banken L and Osterrieder W (1989) Effect of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: Comparison with verapamil. J Cardiovasc Pharmacol 14:713-721.
13. Clozel J-P, Véniant M and Osterrieder W (1990) The structurally novel calcium channel blocker Ro 40-5967, which binds to the [3H]desmethoxyverapamil receptor, is devoid of the negative inotropic effects of verapamil in normal and failing rat hearts. Cardiovasc Drugs Ther 4:731-736.
14. Clozel J-P, Osterrieder W, Kleinbloesem CH, Welker HA, Schläppi B, Tudor R, Hefti F, Schmitt R and Eggers H (1991) Ro 40-5967: A new nondihydropyridine calcium antagonist. Cardiovasc Drug Rev 9:4-17.
15. Cohen JD (1996) 1995: The year of the calcium antagonist controversy. Curr Opin Nephrol Hypertens 5:214-218.
16. Cremers B, Flesch M, Sudkamp M and Bohm M (1997) Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil. J Cardiovasc Pharmacol 29:692-696.
17. Ertel SI and Clozel J-P (1997) Mibefradil (Ro 40-5967): The first selective T-type calcium channel blocker. Exp Opin Invest Drugs 6:569-582.
18. Ertel SI and Ertel EA (1997) Low-voltage-activated T-type calcium channels. Trends Pharmacol Sei 18:37-42.
19. Furberg CD, Psaty BM and Meyer JV (1995) Nifedipine: Dose related increase in mortality in patients with coronary heart disease. Circulation 92:1326-1331.
20. Grynkiewicz G, Poenie M and Tsien RY (1985) A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
21. Hahn M, Tkachuk VA, Bochkov VN, Cheglakov IB and Clozel J-P (1995) Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): Effects on intracellular calcium and platelet aggregation. Cardiovasc Drugs Ther 9:815-821.
22. Hefti F, Clozel J-P and Osterrieder W (1990) Antihypertensive properties of the novel calcium antagonist (lS,2S)-2-[2-[[3-(2-benzimidazolyl)prophyl]methylamino]ethyl]-6-fluoro-l,2,3,4- tetrahydro-l-isopropyl-2-naphtylmethoxyacetatedi-hydrochloride in rat models of hypertension; comparison with verapamil. Arzneim Forsch 40:417-421.
23. Hofmann F, Biel M and Flockerzi V (1994) Molecular basis for calcium channel diversity. Annu Rev Neurosci 17:399-418.
24. Hrnciar J, Hrnciarova M and Jakubikova K (1997) The role of calcium inhibitors in the treatment of arterial hypertension. Vnitr Lek 43:74-80.
25. Karila-Cohen D, Dubois-Rande JL, Giudicelli JF and Berdeaux A (1996) Effects of mibefradil on large and small coronary arteries in conscious dogs: Role of vascular endothelium. J Cardiovasc Pharmacol 28:271-277.
26. Lacinova L, Welling A, Bosse E, Ruth P, Flockerzi V and Hofmann F (1995) Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1 subunit of the cardiac L-type calcmm channel. J Pharmacol Exp Ther 274:54-63.
27. Landmark K, Forsman M, Lindberg K, Ryman T, Martmann-Moe K, Haaverstad S and Wiel S (1995) Nitrendipine and mefruside in elderly hypertensives: Effects on blood pressure, cardiac output, cerebral blood flow and metabolic parameters. J Hum Hypertens 9:281-285.
28. Levy BI, Duriez M, Phillipe M, Poitevin P and Michel JE (1994) Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats. Circulation 90:3024-3033.
29. Li JS and Schiffrin EL (1996) Effect of calcium channel blockade or angiotensinconverting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol 28:68-74.
30. Li JS and Schiffrin EL (1997) Effect of short-term treatment of SHR with the novel calcium channel antagonist mibefradil on function of small arteries. Am J Hypertension 10:94-100.
31. Liang-Min F and Osterrieder W (1991) Potential-dependent inhibition of cardiac calcium inward currents by Ro 40-5967 and verapamil: Relation to negative inotropy. Ear J Pharmacol 196:205-207.
32. Mangoni M, Leuranguer V, Bourinet E and Nargeot JSR (1997) Block of cardiac calcium channels by the new calcium antagonist Ro 40-5967: Consequences on heart rate and cardiac output. Biophys J 72:A256.
33. Mehrke G, ZongXG, Flockerzi V and Hofmann F (1994) The calcium channel blocker Ro 49-5967 blocks differently T-type and L-type calcium channels. J Pharmacol Exp Ther 271:1483-1488.
34. Mishra SK and Hermsmeyer K ( 1994a) Resting state block and use independence of rat vascular muscle calcium channels by Ro 40-5967. J Pharmacol Exp Ther 269:178-183.
35. Mishra SK and Hermsmeyer K (1994b) Selective inhibition of T-type calcium channels by Ro 40-5967. Circ Res 75:144-148.
36. Mulder P, Richard V, Compagnon P, Henry JP, Lallemand F, Clozel J-P, Koen R, Mace B and Thuillez C (1997) Increased survival after long-term treatment with mibefradil, a selective T-channel calcium antagonist, in heart failure. J Am Coll Cardiol 29:416-421.
37. Osterrieder W and Hoick M (1989) In vitro pharmacologie profile of Ro 40-5967, a novel calcium channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol 13:754-759.
38. Palma-Gamiz JL (1997) High blood pressure and calcium antagonism. Cardiology 88:39-46.
39. Python CP, Laban OP, Rossier MF, Vallotton MB and Capponi AM (1995) The site of action of calcium in the activation of steroidogenesis: Studies in calciumclamped bovine adrenal zona glomerulosa cells. Biochem. J. 305:569-576.
40. Ratner EI, Bochkov VN and Tkachuk VA (1996) Comparison of binding of [3H]desmethoxyverapamil and [3H]-mibefradil in vascular smooth muscle and heart membranes. Possible binding of mibefradil to a site distinct from the phenylalkylamine binding site. Arzneim Forsch 46:953-955.
41. Rohacs T, Bago A, Deak F, Hunyady L and Spät A (1994) Capacitative calcium influx in adrenal glomerulosa cells: Possible role in angiotensin II response. Am J Physiol 267:C1246-C1252.
42. Rossier MF, Python CP, Capponi AM, Schlegel W, Kwan CY and Vallotton MB ( 1993 ) Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells. Endocrinology 132:1035-1043.
43. Rossier MF, Aptel HBC, Python CP, Burnay MM, Vallotton MB and Capponi AM (1995) Inhibition of low threshold calcium channels by angiotensin II in adrenal glomerulosa cells through activation of protein kinase C. J Biol Chem 270:1513715142.
44. Rossier MF, Burnay MM, Vallotton MB and Capponi AM ( 1996) Distinct functions of T-type and L-type calcium channels during activation of bovine adrenal glomerulosa cells. Endocrinology 137:4817-4826.
45. Roux S, Bühler M and Clozel J-P (1996) Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: Comparison with amlodipme. J Cardiovasc Pharmacol 27:132-139.
46. Rutledge A and Triggle DJ (1995) The binding interactions of Ro 40-5967 at the L-type calcium channel in cardiac tissue. Ear J Pharmacol 280:155-158.
47. Schmitt R, Clozel J-P, Iberg N and Buhler FR (1995) Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. Arterioscler Thromb Vase Biol 15:1161-1165.
48. Schulz J, Schmidt J and Ruck W (1996) The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy). Curr Med Res Opin 13:397-408.
49. Schuster A, Lacinova L, Klugbauer N, Ito H, Birnbaumer L and Hofmann F (1996) The IVS6 segment of the L-type calcium channels is critical for the action of dihydropyridines and phenylalkylamines. EMBO J 15:2365-2370.
50. Shibasaki M, Inagaki O and Takenaka T (1994) Hemodynamic effects of barnidipine hydrochloride in conscious squirrel monkeys. Gen Pharmacol 25:565-568.
51. Toyo-Oka T and Nayler WG (1996) Third generation calcium entry blockers. Blood Press 5:206-208.
52. Van Zwieten PA, Pfaffendorf M and Mancia G (1996) Attempts to improve the selectivity of calcium antagonistic drugs. Blood Press 5:7-9.
53. Veniant M, Clozel J-P, Hess P and Wolfgang R (1991) Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction. J Cardiovasc Pharmacol 17:277-284.
54. Welling A, Lacinova L, Donatin K, Ludwig A, Bosse E, Flockerzi V and Hofmann F (1995) Expression of the L-type calcium channel with two different beta subunits and its modulation by Ro 40-5967. Pflugers Arch 429:400-411.
55. Zanchetti A (1996) Current position of calcium antagonists in hypertension. J Hypertension 14:S11-S15.